AKRO - Akero Therapeutics stock slides on pricing upsized ~$200.0M stock offering
- Akero Therapeutics ( NASDAQ: AKRO ) shares are down 2.53% after-hours after the firm prices an upsized underwritten public offering of 7,692,308 shares of its common stock at a public offering price of $26.00/share for expected gross proceeds to be ~$200.0M.
- All of the shares in the offering are being offered by Akero Therapeutics.
- Underwriters are granted a 30-day option to purchase up to an additional 1,153,846 shares of its common stock.
- Offering is expected to close on or about September 19, 2022.
- Earlier, Akero Therapeutics commences underwritten public offering of $175M of shares .
For further details see:
Akero Therapeutics stock slides on pricing upsized ~$200.0M stock offering